By Sheila Omondi, Practice Lead, Clinical Planning and Strategy Consulting At the recent Summit for Clinical Ops Executives (SCOPE), discussions surrounding diversity in clinical trials persisted, underscoring a decade-long struggle to effect meaningful change. Despite the attention it has garnered, progress remains sluggish, prompting reflection on the industry's pace of innovation. Addressing this challenge demands deliberate, proactive efforts across the research continuum.
